Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

cloZAPine

cloZAPine
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
FazaClo TABLET, DISINTEGRATING, ORAL 12.5 mg, 25 mg, 100 mg    
Clozaril TABLET, ORAL 25 mg, 100 mg      
VIEW MORE Atypical Antipsychotics
CLASS
28160804
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

cloZAPine (FazaClo)

  • 12.5 mg ODT
  • 25 mg ODT
  • 100 mg ODT

cloZAPine (Clozaril)

  • Half 25 mg tablet oral (Total: 12.5 mg)
  • 25 mg tablet oral
  • 100 mg tablet oral

Automatically interchange cloZAPine orally disintegrating tablets to the regular tablet at the same dose.

 

Upon clozapine verification CBC w/differential should be obtained (if not already performed).  If ANC results <1000 please contact MD.  If ANC acceptable redraw in 2 weeks.  Follow up to be performed in Sentri-7. 

 

Reviewed: December 12, 2007 (cloZAPine ODT)

REMS (Clozaril, FazaClo, cloZAPine): View FDA REMS Info

Last updated: Mar. 11, 2025






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2025 Rpharmy, LLC ­ All Rights Reserved